Holladay, F. P., T. Heitz, et al. (1992) . "Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells." J Neurosurg 77(5): 757-62. 80. Hu, J., I. McNeish, et al. (2003). "A phase I clinical trial with OncoVEXGMCSF." Molecular Therapy 7(5): S447. 81. Huang, A. Y., P. Golum bek, et al. (1994). "Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens." Science 264 (5161): 961-5. 82. Jachimczak, P., U. Bogdahn, et al. (1993) . "The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma." J Neurosurg 78(6): 944-51. 83.